Encephalitozoon cuniculi (E. cuniculi) is a microsporidian (intracellular) parasite that commonly infects domestic rabbits. Seroprevalence studies indicate that a large proportion of pet rabbits — estimated at 40 to 80% depending on the population — have been exposed to E. cuniculi, though many remain asymptomatic. When clinical disease develops, it most commonly affects the brain (causing vestibular disease and head tilt), the kidneys (causing chronic renal disease), and the eyes (causing phacoclastic uveitis — lens rupture). E. cuniculi is one of the most important differential diagnoses for head tilt in pet rabbits, alongside pasteurellosis.
Overview
E. cuniculi is transmitted primarily through ingestion or inhalation of spores shed in the urine of infected rabbits. Spores can survive in the environment for weeks to months. Vertical transmission (from mother to offspring) also occurs. After ingestion, the organism spreads hematogenously (through the bloodstream) to target organs — primarily the brain, kidneys, and lens of the eye.
The immune response is important: rabbits with healthy immune systems may keep the infection in check indefinitely without showing clinical signs. Disease typically develops when immune function is compromised by stress, concurrent illness, old age, or corticosteroid use.
E. cuniculi is considered a potential zoonotic organism, primarily of concern for immunocompromised humans (HIV/AIDS patients, transplant recipients). The risk to healthy humans is considered very low.
Symptoms
Neurological (Most Common Clinical Presentation)
- Head tilt (torticollis) — Persistent tilting of the head to one side; the hallmark sign
- Loss of balance, ataxia, circling
- Rolling (severe vestibular episodes where the rabbit rolls uncontrollably)
- Nystagmus (involuntary rapid eye movements)
- Hind limb weakness or paralysis (from spinal cord involvement)
- Seizures (less common)
- Urinary incontinence (from spinal cord or brain involvement)
Renal
- Increased thirst and urination
- Weight loss
- Decreased appetite
- Chronic kidney disease (may be subclinical for a long time)
Ocular
- Phacoclastic uveitis — Rupture of the lens capsule by E. cuniculi organisms growing within the lens, causing intense uveitis (intraocular inflammation). Presents as a white mass visible in the eye, eye redness, and pain. Typically unilateral.
- Cataracts (in some cases without lens rupture)
Diagnosis
Definitive diagnosis of E. cuniculi as the cause of clinical signs is challenging:
- Serology (antibody testing) — Detects IgG and IgM antibodies against E. cuniculi. A positive IgG indicates exposure but not necessarily active disease (given the high seroprevalence). A positive IgM may suggest recent or active infection. A negative result makes E. cuniculi less likely as the cause of current symptoms.
- Paired titers — A rising titer over 2 to 4 weeks supports active infection.
- PCR — PCR testing of urine may detect shedding, but negative results do not rule out infection (shedding is intermittent).
- Blood work — May reveal elevated kidney values (BUN, creatinine) in renal disease. Urine specific gravity may be decreased.
- Skull radiographs or CT — Important to differentiate E. cuniculi-related vestibular disease from pasteurella otitis media (middle ear infection). CT is significantly more informative.
- Ocular examination — Phacoclastic uveitis (white intralenticular mass) is strongly suggestive of E. cuniculi.
- Post-mortem histopathology — Definitive diagnosis is often made only at necropsy, identifying characteristic granulomatous inflammation and organisms in brain and kidney tissue.
In practice, a rabbit with head tilt and a positive E. cuniculi titer, with imaging that rules out middle ear disease, is treated presumptively for E. cuniculi.
Treatment & Medications
| Medication | Purpose | Key Notes |
|---|---|---|
| Fenbendazole (Panacur) | Kills E. cuniculi organisms | The primary treatment. Dosed at 20 mg/kg orally once daily for a minimum of 28 days. Some specialists recommend longer courses. Does not cross the blood-brain barrier efficiently, so treatment targets organisms in other tissues and may prevent further brain damage rather than reverse existing damage. |
| Meloxicam | NSAID for pain and inflammation | Reduces inflammation in affected tissues and provides analgesia. |
| Meclizine | Anti-vertigo / anti-nausea | Helps manage vestibular symptoms (nausea, dizziness) during the acute phase. |
| Maropitant (Cerenia) | Anti-nausea | For severe nausea associated with vestibular episodes. |
| Dexamethasone (controversial) | Reduce acute brain inflammation | Used by some veterinarians in the acute phase to reduce CNS inflammation. Controversial because corticosteroids can immunosuppress the rabbit and potentially worsen E. cuniculi replication. Short-term use only, if at all. |
Supportive Care
- Padded enclosure — Prevent injury during rolling episodes. Remove hard objects and provide soft bedding.
- Syringe feeding — If the rabbit is unable to eat due to disorientation or nausea.
- Fluid therapy — Subcutaneous fluids if the rabbit is dehydrated or has renal disease.
- Assistance with grooming and cleaning — Rabbits with vestibular disease or hind limb weakness may need help staying clean.
- Physical therapy — Gentle exercises to encourage balance and mobility as the rabbit recovers.
Phacoclastic Uveitis Treatment
- Anti-inflammatory eye drops (topical NSAIDs, corticosteroids)
- Atropine eye drops (for pain and pupil dilation)
- Enucleation (eye removal) may be necessary if the uveitis is severe, painful, and unresponsive to medical management
- Phacoemulsification (lens removal) is performed at some specialty centers
Prognosis
- Mild head tilt — Fair to good prognosis. Many rabbits improve significantly with fenbendazole treatment and supportive care. Some residual head tilt may remain but rabbits adapt well.
- Severe vestibular disease (rolling, inability to stand) — More guarded. Some rabbits recover slowly over weeks to months; others do not improve sufficiently to maintain quality of life.
- Hind limb paralysis — Guarded to poor prognosis. Recovery is possible but less likely than with vestibular signs.
- Renal disease — Chronic and progressive. Can be managed supportively but not cured.
- Phacoclastic uveitis — Vision in the affected eye is typically lost, but rabbits adapt well to monocular vision. Enucleation resolves the pain if medical management fails.
Frequently Asked Questions
Will the head tilt go away completely? Some rabbits fully recover, while others retain a mild residual head tilt. Many rabbits with residual tilt adapt remarkably well and maintain excellent quality of life. Improvement may continue over weeks to months after starting treatment.
Is E. cuniculi contagious to my other rabbits? Yes. E. cuniculi spores are shed in urine and can survive in the environment. Other rabbits in the household have likely already been exposed. Testing housemates may be helpful, but many seropositive rabbits never develop clinical disease.
Can I catch E. cuniculi from my rabbit? E. cuniculi is considered a very low risk to healthy humans. It is primarily a concern for severely immunocompromised individuals (HIV/AIDS, organ transplant recipients on immunosuppressants). Standard hygiene practices (hand washing after handling rabbits, cleaning litter areas) are protective.
Should I treat my seropositive but asymptomatic rabbit? This is debated. Some veterinarians recommend a prophylactic 28-day fenbendazole course to reduce the organism burden. Others reserve treatment for symptomatic animals. Discuss with your rabbit-experienced veterinarian.
Can E. cuniculi come back after treatment? Yes. Fenbendazole may not completely eliminate the organism from an infected rabbit. Relapse can occur, particularly during periods of immunosuppression or stress.